KL Acquisition Corp
KLAQ
NASDAQ Capital Market10.09
USD
+0.03
- -
KL Acquisition Corp
KLAQ
(NASDAQ Capital Market)
Recent
price
10.09
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- KL Acquisition Corp operated as a special purpose acquisition company, having been established in 2020 to pursue a merger, capital stock exchange, asset acquisition, or similar business combination. The firm's initial investment strategy concentrated on the life sciences sector, specifically targeting companies involved in medical devices, diagnostics, and various life sciences tools and instrumentation. After its initial public offering in January 2021, the company did not proceed with a business combination. Consequently, in December 2022, KL Acquisition Corp redeemed its public shares, and its securities were subsequently delisted and deregistered. The entity had no direct operations or revenue generation, serving solely as a vehicle for a potential acquisition. It was based in New York, New York.